Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Alexandra Kropotova Insider Profile
4 Followers
Alexandra Kropotova, Director at Ibio, holds ― shares in Ibio (Ticker: IBIO), holds 48.43K shares in SAB Biotherapeutics (Ticker: SABS). Most recently, Alexandra Kropotova ― shares of Ibio on ― for an estimated value of ―.
Alexandra Kropotova has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Alexandra Kropotova
Alexandra Kropotova's Trading History
Ibio
―
Director
―
―
SAB Biotherapeutics
Dec 31, 2024
CMO
Uninformative Sell
―
$177.73K
List of latest transactions for each holding click on a transaction to see Alexandra Kropotova's performance on stock
You May Also Like
Alexandra Kropotova insider profile FAQ
What is the percentage of profitable transactions made by Alexandra Kropotova?
The percentage of profitable transactions made by Alexandra Kropotova is ―.
What is the average return per transaction made by Alexandra Kropotova?
The average return per transaction made by Alexandra Kropotova is ―.
What stocks does Alexandra Kropotova hold?
Alexandra Kropotova holds: IBIO, SABS stocks.
What was Alexandra Kropotova’s latest transaction?
Alexandra Kropotova latest transaction was an Uninformative Buy of ―.
What was Alexandra Kropotova's most profitable transaction?
Alexandra Kropotova’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Alexandra Kropotova's role in Ibio?
Alexandra Kropotova's role in Ibio is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.